Fatty Acid Metabolism in Pulmonary Arterial Hypertension: Role in Right Ventricular Dysfunction and Hypertrophy
暂无分享,去创建一个
[1] E. Brittain,et al. Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension , 2014, Pulmonary circulation.
[2] T. Fukuda,et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty , 2014, European Respiratory Journal.
[3] L. Gleaves,et al. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.
[4] J. Ioannidis,et al. Geometry of the randomized evidence for treatments of pulmonary hypertension. , 2013, Cardiovascular therapeutics.
[5] A. Criollo,et al. Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death. , 2013, Biochimica et biophysica acta.
[6] S. Archer,et al. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension , 2013, Journal of Molecular Medicine.
[7] S. Erzurum,et al. Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. , 2013, Annals of the American Thoracic Society.
[8] J. Bigbee,et al. Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension , 2013, Circulation. Heart failure.
[9] S. Archer,et al. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate , 2012, Journal of Molecular Medicine.
[10] Y. Takemura,et al. Loss of ACE2 Exaggerates High-Calorie Diet–Induced Insulin Resistance by Reduction of GLUT4 in Mice , 2012, Diabetes.
[11] R. Souza,et al. Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension? , 2012, The American journal of cardiology.
[12] W. Seeger,et al. HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance? , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] L. Gleaves,et al. A potential role for insulin resistance in experimental pulmonary hypertension , 2012, European Respiratory Journal.
[14] N. Voelkel,et al. Pathobiology of pulmonary arterial hypertension and right ventricular failure , 2012, European Respiratory Journal.
[15] J. Brugada,et al. Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart , 2012, PloS one.
[16] S. Archer,et al. Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension , 2012, Circulation research.
[17] A. Praestgaard,et al. Insulin Resistance And Right Ventricular Structure And Function: The MESA-Right Ventricle Study , 2012, ATS 2012.
[18] A. Bonen,et al. Caffeine‐stimulated fatty acid oxidation is blunted in CD36 null mice , 2012, Acta physiologica.
[19] M. Tadic,et al. Metabolic syndrome and left ventricular function: Is the number of criteria actually important? , 2012, Medical science monitor : international medical journal of experimental and clinical research.
[20] R. Hamid,et al. Pulmonary Circulation | April-june 2012 | Vol 2 | No 2 Research Ar Ticle Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic Reprogramming Several Animal Models of Pah , 2022 .
[21] S. Archer,et al. Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[22] Nico Westerhof,et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. , 2011, Journal of the American College of Cardiology.
[23] Christian M. Metallo,et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.
[24] A. Einstein,et al. PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension , 2011, Circulation. Cardiovascular imaging.
[25] D. Ouwens,et al. Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice. , 2011, American journal of physiology. Endocrinology and metabolism.
[26] N. Yazıhan,et al. Impaired right ventricular functions in metabolic syndrome patients with preserved left ventricular ejection fraction. , 2011, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[27] P. Fawcett,et al. Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. , 2011, American journal of respiratory cell and molecular biology.
[28] Jennifer A. Johnson,et al. ACE2 Improves Right Ventricular Function in a Pressure Overload Model , 2011, PloS one.
[29] G. Ewald,et al. Intramyocardial triglyceride quantification by magnetic resonance spectroscopy: In vivo and ex vivo correlation in human subjects , 2011, Magnetic resonance in medicine.
[30] M. Tadic,et al. Metabolic Syndrome Impacts the Right Ventricle: True or False? , 2011, Echocardiography.
[31] J. Dyck,et al. Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction , 2011, Journal of Molecular Medicine.
[32] C. Dang,et al. Therapeutic targeting of cancer cell metabolism , 2011, Journal of Molecular Medicine.
[33] D. Gardner,et al. A Murine Model of Isolated Cardiac Steatosis Leads to Cardiomyopathy , 2011, Hypertension.
[34] R. Dweik,et al. Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.
[35] S. Koh,et al. Cardiovascular Parameters Correlated with Metabolic Syndrome in a Rural Community Cohort of Korea: The ARIRANG Study , 2010, Journal of Korean medical science.
[36] T. Rice,et al. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[37] J. Mitchell,et al. The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension , 2010, PloS one.
[38] Jeroen J. Bax,et al. Myocardial Steatosis and Biventricular Strain and Strain Rate Imaging in Patients With Type 2 Diabetes Mellitus , 2010, Circulation.
[39] I. Goldberg,et al. Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α Activators , 2010, Circulation.
[40] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[41] A. Bonen,et al. FAT/CD36-null mice reveal that mitochondrial FAT/CD36 is required to upregulate mitochondrial fatty acid oxidation in contracting muscle. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[42] S. Toyooka,et al. Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension. , 2009, The Journal of thoracic and cardiovascular surgery.
[43] S. Srinivasan,et al. Influence of the metabolic syndrome versus the sum of its individual components on left ventricular geometry in young adults (from the Bogalusa Heart Study). , 2009, The American journal of cardiology.
[44] H. Turhan,et al. The impact of metabolic syndrome on left ventricular function: evaluated by using the index of myocardial performance. , 2009, International journal of cardiology.
[45] Azra Mahmud,et al. Left ventricular structural and functional changes in the metabolic syndrome. , 2009, Journal of the cardiometabolic syndrome.
[46] Kohtaro Abe,et al. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. , 2009, Chest.
[47] L. Kalabay,et al. Does the dynamicity of weight gain predict elements of metabolic syndrome? Differences in weight gain of hypertensive, diabetic, and obese elderly patients: a pilot study in primary care. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[48] G. Hansmann,et al. Insulin resistance in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[49] F. Lopez‐Jimenez,et al. Abnormal cardiac structure and function in the metabolic syndrome: a population-based study. , 2008, Mayo Clinic proceedings.
[50] G. Lopaschuk,et al. The malonyl CoA axis as a potential target for treating ischaemic heart disease. , 2008, Cardiovascular Research.
[51] C. Lewis,et al. Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study , 2008, Journal of hypertension.
[52] G. Dbaibo,et al. Modulation of total ceramide and constituent ceramide species in the acutely and chronically hypoxic mouse heart at different ages. , 2008, Prostaglandins & other lipid mediators.
[53] D. Ouwens,et al. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification , 2007, Diabetologia.
[54] C. Doe,et al. PPARδ Activation Normalizes Cardiac Substrate Metabolism and Reduces Right Ventricular Hypertrophy in Congestive Heart Failure , 2007 .
[55] H. Hense,et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities – cross-sectional study of the general population , 2007, BMC cardiovascular disorders.
[56] Xianlin Han,et al. CD36 Deficiency Rescues Lipotoxic Cardiomyopathy , 2007, Circulation research.
[57] A. Bonen,et al. AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. , 2007, Biochemical and biophysical research communications.
[58] Raed A Dweik,et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[59] G. Mancia,et al. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis , 2007, Hypertension.
[60] R. Gropler,et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.
[61] M. Gladwin,et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.
[62] K. Jishage,et al. Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury , 2006, Circulation.
[63] K. Clarke,et al. Modification of myocardial substrate use as a therapy for heart failure , 2006, Nature Clinical Practice Cardiovascular Medicine.
[64] T. Pulinilkunnil,et al. Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3 , 2006, Diabetologia.
[65] B. Groves,et al. Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. , 2006, European journal of medical research.
[66] G. Semenza,et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.
[67] Y. Kagaya,et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. , 2005, Journal of the American College of Cardiology.
[68] N. Renna,et al. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. , 2005, American journal of hypertension.
[69] H. Galbo,et al. Expression profiling reveals differences in metabolic gene expression between exercise‐induced cardiac effects and maladaptive cardiac hypertrophy , 2005, The FEBS journal.
[70] R. Heine,et al. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats , 2005, Diabetologia.
[71] W. Wahli,et al. Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes , 2005 .
[72] Michael D. Schneider,et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.
[73] Titus Kuehne,et al. Magnetic Resonance Imaging Analysis of Right Ventricular Pressure-Volume Loops: In Vivo Validation and Clinical Application in Patients With Pulmonary Hypertension , 2004, Circulation.
[74] M. Buckingham,et al. Right Ventricular Myocardium Derives From the Anterior Heart Field , 2004, Circulation research.
[75] M. Chandler,et al. Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation , 2004, Circulation research.
[76] A. Bonen,et al. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. , 2004, Biochemical Society transactions.
[77] M. van Bilsen,et al. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. , 2003, Acta physiologica Scandinavica.
[78] R. Dobrowsky,et al. A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids* , 2003, The Journal of Biological Chemistry.
[79] G. Metzger,et al. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.
[80] A. Zorzano,et al. Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. , 2002, Diabetes.
[81] T. Nakata,et al. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. , 2001, Journal of lipid research.
[82] P. Herrero,et al. A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.
[83] T. Myrmel,et al. Myocardial substrate metabolism influences left ventricular energetics in vivo. , 2000, American journal of physiology. Heart and circulatory physiology.
[84] G. J. van der Vusse,et al. Cardiac fatty acid uptake and transport in health and disease. , 2000, Cardiovascular research.
[85] S. Hamada,et al. Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[86] Y. Sawada,et al. Detection of impaired fatty acid metabolism in right ventricular hypertrophy: Assessment by I-123 β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography , 1997, Annals of nuclear medicine.
[87] J. Mccormack,et al. Regulation of energy substrate metabolism in the diabetic heart. , 1997, Cardiovascular research.
[88] G. Lopaschuk,et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. , 1997, Cardiovascular research.
[89] C. R. Smith,et al. Variability of right ventricular functional recovery after lung transplantation. , 1996, Transplantation.
[90] B. Griffith,et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. , 1996, Journal of the American College of Cardiology.
[91] M. Pasque,et al. Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. , 1995, Circulation.
[92] Y. Kagaya,et al. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. , 1995, Cardiovascular research.
[93] J. Sandoval,et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.
[94] H. Valantine,et al. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. , 1994, The American journal of cardiology.
[95] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[96] E. Trulock,et al. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. , 1991, Journal of the American College of Cardiology.
[97] B. Hoit,et al. Doppler assessment of changes in right-sided cardiac hemodynamics after pulmonary thromboendarterectomy. , 1988, The American journal of cardiology.
[98] K. Peterson,et al. Early changes of right heart geometry after pulmonary thromboendarterectomy. , 1988, Journal of the American College of Cardiology.
[99] O. Nishiyama,et al. Right and left ventricular oxygen metabolism in open-chest dogs. , 1982, The American journal of physiology.
[100] J. Kjekshus,et al. The Effect of Free Fatty Acids on Myocardial Oxygen Consumption During Atrial Pacing and Catecholamine Infusion in Man , 1978, Circulation.
[101] E. Newsholme,et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.
[102] R. Bing,et al. Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart. , 1953, The American journal of medicine.
[103] R. Sichieri,et al. Heart energy metabolism impairment in Western-diet induced obese mice. , 2014, The Journal of nutritional biochemistry.
[104] R. Schwenk,et al. CD36 as a target to prevent cardiac lipotoxicity and insulin resistance. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.
[105] S. Archer,et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle , 2011, Journal of Molecular Medicine.
[106] D. Badesch,et al. Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey , 2011 .
[107] I. Haber,et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle , 2009, Journal of Molecular Medicine.
[108] A. Bonen,et al. Insulin-induced translocation of CD36 to the plasma membrane is reversible and shows similarity to that of GLUT4. , 2008, Biochimica et biophysica acta.
[109] O. Sabri,et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[110] P. J. Randle,et al. Glucose fatty acid interactions and the regulation of glucose disposal , 1994, Journal of cellular biochemistry.